If you're in your 40s or 50s and working hard to lose weight, there's good news: your efforts could lead to a longer, healthier life. A new study finds that…
If your grocery cart is full of boxed, bagged, or frozen meals with mile-long ingredient lists, you’re not alone. Ultraprocessed foods are convenient and cheap—but mounting research shows they’re fueling…
GLP-1 receptor agonists, including Ozempic, Wegovy, and Mounjaro, are commonly prescribed for type 2 diabetes and weight management. Understanding the early adjustment period helps set realistic expectations. Exercise your brain…
Living with type 2 diabetes doesn’t mean you’re destined for complications. While high blood sugar over time can harm the body in serious ways, the good news is this: many…
Recent advances in weight loss medications, particularly GLP-1 receptor agonists, have generated unprecedented excitement in obesity treatment. While these medications represent significant progress, understanding their potential and limitations is crucial…
These tiny patches are trending—but do they really help healthy people eat better? They’re about the size of a quarter, stick to your arm like a nicotine patch, and promise…
Intermittent fasting has been making waves in the health world for a while now, praised for everything from weight loss to brain health. But lately, there’s been a heated debate…
When exhaustion is more than “just part of life with diabetes” Living with diabetes can feel like a full-time job—but what happens when you’re too tired to clock in? If…
For years, insulin has symbolized everything broken about prescription drug pricing in America. A medication first developed more than a century ago has somehow become almost unaffordable for many families—often…
California Governor Gavin Newsom has stepped directly into one of the biggest healthcare debates of the decade: the soaring cost and growing demand for GLP-1 medications like Ozempic, Wegovy, and…